Voice changes in women treated for endometriosis and related conditions: the need for comprehensive vocal assessment.
Hormonal treatments which have an androgenic effect have the potential to cause vocal changes. The changes in vocal fold structure and voice quality are considered to be irreversible. To date, studies have documented subjective vocal changes or documented single cases without detailed, baseline voice assessments. The impact on laryngeal function of women taking these androgenic treatments requires further detailed, objective assessment. The need for increased awareness of the actions of androgenic hormones on womens' voices, and the benefits of a thorough voice assessment are discussed.
Pattie
M A
MA
Department of Speech Pathology and Audiology, University of Queensland, St. Lucia, Australia.
Murdoch
B E
BE
Theodoros
D
D
Forbes
K
K
D003613:Danazol / Q000494:pharmacology* / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D014831:Voice / Q000187:drug effects*; D014832:Voice Disorders / Q000175:diagnosis*; D014833:Voice Quality
D004965:Estrogen Antagonists; D003613:Danazol